Compare RLYB & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLYB | NMTC |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7M | 34.3M |
| IPO Year | 2021 | 2010 |
| Metric | RLYB | NMTC |
|---|---|---|
| Price | $10.66 | $0.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | N/A | ★ $1.98 |
| AVG Volume (30 Days) | 201.4K | ★ 205.0K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.72 | ★ 80.43 |
| EPS | N/A | ★ N/A |
| Revenue | $600,000.00 | ★ $9,097,692.00 |
| Revenue This Year | $17.61 | N/A |
| Revenue Next Year | N/A | $32.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 163.47 |
| 52 Week Low | $0.22 | $0.40 |
| 52 Week High | $11.20 | $1.15 |
| Indicator | RLYB | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 92.99 | 56.95 |
| Support Level | $0.48 | $0.70 |
| Resistance Level | N/A | $0.86 |
| Average True Range (ATR) | 0.76 | 0.07 |
| MACD | 0.55 | 0.00 |
| Stochastic Oscillator | 89.39 | 81.64 |
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.